The diagnosis of inflammatory bowel disease (IBD) at age over 60 years is between 10 and 15% of all IBD. This frequency is increasing due to the ageing of the population however, this group of elderly patients remains little studied and excluded from clinical trials. This was a retrospective study that included patients with IBD in the gastroenterology department between January 1, 2007 and December 31, 2015. The patients included were divided into two groups: group A patients in whom the diagnosis of IBD was made at an age greater than or equal to 60 years and group B including the subjects in whom the diagnosis of IBD was made at a younger age. A total of 305 subjects were included in the study, 30 of whom were over 60 years of age at the time of diagnosis of IBD, counting for a frequency of 9.8%. Among the elderly, 53.5% were between 60 and 70 years of age. Male predominance was noted in elderly subjects with a statistically significant difference from younger subjects (70% vs. 48%, p = 0.02). The elderly group had more patients with UC with a significant difference (73.3% vs. 58.2%, p = 0.008). The comparative analysis found no statistically significant differences in the extent of UC, the location and phenotype of Crohn’s disease between the two groups. In the elderly, subocclusive syndromes (0% vs. 13.5%, p = 0.03) and abdominal pain (26.7% vs. 49.1%, p = 0.02) were found less frequently. On the other hand, in elderly subjects, hypokalaemia was more frequently noted with a significant difference (23.3% vs. 9.1%, p = 0.025). Compared with younger subjects, elderly patients had fewer flares (0.11 vs. 0.21, p = 0.048) and fewer hospitalisations (1.53 vs.. 2.18, p = 0.034). We did not find any significant difference in the comparative analysis between the two groups regarding mortality and duration of follow-up. We found significantly more adverse effects on salicylates in the elderly (26.7% vs. 10.5%, p = 0.017). There was no significant difference in the frequency of surgery between the two groups. Our study found a high incidence of male and UC in IBD starting after the age of 60 with a more frequently atypical initial clinical presentation and fewer abdominal pain and subocclusive syndromes than younger subjects. The high frequency of comorbidities and hypokalaemia in elderly patients implies greater caution in the management of these patients. Although we were able to demonstrate a low incidence of severe relapses / year and a lower use of corticosteroids in the elderly relative to the young subject, adverse effects to salicylates were more frequent in these patients, which requires closer surveillance from the prescribers.